These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6387690)

  • 1. The CREST syndrome--successful reduction of pulmonary hypertension by captopril.
    Prouse PJ; Lahiri A; Gumpel JM
    Postgrad Med J; 1984 Oct; 60(708):672-4. PubMed ID: 6387690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of captopril in the treatment of systemic arterial and pulmonary hypertension with increased plasma renin in scleroderma].
    Richard C; Ricome JL; Lemoine F; Rimailho A; Lantz O; Auzépy P
    Rev Med Interne; 1983 Jun; 4(2):125-9. PubMed ID: 6351212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril in primary pulmonary hypertension.
    Leier CV; Bambach D; Nelson S; Hermiller JB; Huss P; Magorien RD; Unverferth DV
    Circulation; 1983 Jan; 67(1):155-61. PubMed ID: 6336605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of captopril (SQ 14,225) in a patient with primary pulmonary hypertension.
    Horowitz JD; Brennan JB; Oliver LE; Harding D; Goble AJ; Louis WJ
    Postgrad Med J; 1981 Feb; 57(664):115-6. PubMed ID: 7022422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and long-term hemodynamic effects of captopril in patients with pulmonary hypertension and selected connective tissue disease.
    Alpert MA; Pressly TA; Mukerji V; Lambert CR; Mukerji B
    Chest; 1992 Nov; 102(5):1407-12. PubMed ID: 1424860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant arterial hypertension in scleroderma. Beneficial effects of captopril on pulmonary and systemic vascular resistance].
    Bonnet F; Matamis D; Lepresle E; Cabane J; Le Gall JR
    Nouv Presse Med; 1982 May; 11(20):1570-1. PubMed ID: 7048249
    [No Abstract]   [Full Text] [Related]  

  • 7. Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment.
    Rich S; Martinez J; Lam W; Rosen KM
    Br Heart J; 1982 Sep; 48(3):272-7. PubMed ID: 7049203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Scleroderma complicated by arterial hypertension and kidney failure: treatment with captopril].
    Flechet ML; Bravard P; Godin M
    Nouv Presse Med; 1981 May; 10(22):1848. PubMed ID: 7015276
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of captopril to reverse the renal crisis of scleroderma.
    Brown EA; Macgregor GA; Maini RN
    Ann Rheum Dis; 1983 Feb; 42(1):52-3. PubMed ID: 6338841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril in the treatment of scleroderma renal crisis.
    Thurm RH; Alexander JC
    Arch Intern Med; 1984 Apr; 144(4):733-5. PubMed ID: 6370160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deterioration of renal function in hypertensive patients with scleroderma despite blood pressure normalization with captopril.
    Waeber B; Schaller MD; Wauters JP; Brunner HR
    Klin Wochenschr; 1984 Aug; 62(15):728-30. PubMed ID: 6387262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma).
    Salerni R; Rodnan GP; Leon DF; Shaver JA
    Ann Intern Med; 1977 Apr; 86(4):394-9. PubMed ID: 848800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unloading the right ventricle in the CREST syndrome variant of progressive systemic sclerosis (scleroderma).
    Morrison D; Goldman S; Alepa FP
    Clin Cardiol; 1984 Jan; 7(1):49-53. PubMed ID: 6231150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Scleroderma complicated by arterial hypertension and renal insufficiency. Favorable effects of captopril].
    Grünfeld JP; Pulik M; Reveillaud RJ; Martinet C
    Nouv Presse Med; 1980 Oct; 9(36):2658. PubMed ID: 7001352
    [No Abstract]   [Full Text] [Related]  

  • 15. [Administration of angiotensin I converting enzyme inhibitor captopril, in a case of renal crisis of scleroderma--the effects of captopril to the temperature of the skin lesion in scleroderma (author's transl)].
    Gotoh S; Ogihara T; Hata T; Maruyama A; Naka T; Nakamaru M; Mikami H; Masuo K; Kumahara Y
    Nihon Jinzo Gakkai Shi; 1981 Aug; 23(8):1133-41. PubMed ID: 7033607
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary hypertension in the CREST syndrome: variant of systemic sclerosis (scleroderma)--a case report.
    Lie JT
    Angiology; 1989 Aug; 40(8):764-7. PubMed ID: 2757266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beneficial effect of the converting enzyme inhibitor on the acute renal failure of scleroderma with arterial hypertension].
    Mercatello A; Zech PY
    Nouv Presse Med; 1981 Apr; 10(19):1596. PubMed ID: 7025853
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypertensive crisis in systemic sclerosis: treatment with the new oral angiotensin converting enzyme inhibitor MK, 421 (Enalapril) in captopril-intolerant patients.
    Smith CD; Smith RD; Korn JH
    Arthritis Rheum; 1984 Jul; 27(7):826-8. PubMed ID: 6331462
    [No Abstract]   [Full Text] [Related]  

  • 19. Is captopril effective in primary pulmonary hypertension?
    Kokubu T; Kazatani Y; Hamada M; Matsuzaki K; Ito T; Nishimura K; Ochi T; Daimon F; Joh T
    Jpn Circ J; 1982 Oct; 46(10):1095-7. PubMed ID: 6750176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical course of patients with scleroderma renal crisis treated with captopril.
    Zawada ET; Clements PJ; Furst DA; Bloomer HA; Paulus HE; Maxwell MH
    Nephron; 1981; 27(2):74-8. PubMed ID: 7022235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.